Truist lifts Boston Scientific stock target to $120, maintains Buy
Truist Securities expressed a positive outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $120 from $110, while reaffirming a Buy rating. The stock, currently trading near its ...
Truist Financial Sticks to Their Buy Rating for Boston Scientific (BSX)
Truist Financial analyst Richard Newitter maintained a Buy rating on Boston Scientific (BSX – Research Report) today and set a price target of ...
Truist Financial Reaffirms Their Buy Rating on Universal Technical Institute (UTI)
Truist Financial analyst Jasper Bibb maintained a Buy rating on Universal Technical Institute (UTI – Research Report) today and set a price ...
DAVENPORT & Co LLC Has $1.35 Million Holdings in Direxion NASDAQ-100 Equal Weighted Index Shares (NASDAQ:QQQE)
DAVENPORT & Co LLC lifted its stake in Direxion NASDAQ-100 Equal Weighted Index Shares (NASDAQ:QQQE – Free Report) by 9.9% during the 4th quarter, HoldingsChannel reports. The fund owned 14,983 shares ...
Greenleaf Trust Acquires 256 Shares of Equity Residential (NYSE:EQR)
Greenleaf Trust increased its holdings in Equity Residential (NYSE:EQR – Free Report) by 7.4% in the fourth quarter, ...
Truist cuts Alphabet stock price target to $220, maintains Buy
Truist Securities adjusted its price target for Alphabet stock (NASDAQ:GOOGL), reducing it to $220 from the previous $225, ...